These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20922335)

  • 1. Can self-reported height and weight be used to calculate 10 year risk of osteoporotic fracture?
    Bridges MJ; Ruddick S
    J Nutr Health Aging; 2010 Oct; 14(8):611-3. PubMed ID: 20922335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fracture risk prediction using FRAX®: a 10-year follow-up survey of the Japanese Population-Based Osteoporosis (JPOS) Cohort Study.
    Tamaki J; Iki M; Kadowaki E; Sato Y; Kajita E; Kagamimori S; Kagawa Y; Yoneshima H
    Osteoporos Int; 2011 Dec; 22(12):3037-45. PubMed ID: 21279504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Setting the new FRAX reference threshold without bone mineral density in Chinese postmenopausal women.
    Liu S; Chen R; Ding N; Wang Q; Huang M; Liu H; Xie Z; Ou Y; Sheng Z
    J Endocrinol Invest; 2021 Feb; 44(2):347-352. PubMed ID: 32495298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Height loss in postmenopausal women-do we need more for fracture risk assessment? Results from the GO Study.
    Pluskiewicz W; Adamczyk P; Drozdzowska B
    Osteoporos Int; 2021 Oct; 32(10):2043-2049. PubMed ID: 33818635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FRAX-based Estimates of 10-year Probability of Hip and Major Osteoporotic Fracture Among Adults Aged 40 and Over: United States, 2013 and 2014.
    Looker AC; Sarafrazi Isfahani N; Fan B; Shepherd JA
    Natl Health Stat Report; 2017 Mar; (103):1-16. PubMed ID: 28459415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can frailty in conjunction with FRAX identify additional women at risk of fracture - a longitudinal cohort study of community dwelling older women.
    Bartosch P; Malmgren L
    BMC Geriatr; 2022 Dec; 22(1):951. PubMed ID: 36494774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos.
    Fraser LA; Langsetmo L; Berger C; Ioannidis G; Goltzman D; Adachi JD; Papaioannou A; Josse R; Kovacs CS; Olszynski WP; Towheed T; Hanley DA; Kaiser SM; Prior J; Jamal S; Kreiger N; Brown JP; Johansson H; Oden A; McCloskey E; Kanis JA; Leslie WD;
    Osteoporos Int; 2011 Mar; 22(3):829-37. PubMed ID: 21161508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment.
    Leslie WD; Lix LM; Langsetmo L; Berger C; Goltzman D; Hanley DA; Adachi JD; Johansson H; Oden A; McCloskey E; Kanis JA
    Osteoporos Int; 2011 Mar; 22(3):817-27. PubMed ID: 21161509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measured height loss predicts incident clinical fractures independently from FRAX: a registry-based cohort study.
    Leslie WD; Schousboe JT; Morin SN; Martineau P; Lix LM; Johansson H; McCloskey EV; Harvey NC; Kanis JA
    Osteoporos Int; 2020 Jun; 31(6):1079-1087. PubMed ID: 32016485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing self-perceived and estimated fracture risk by FRAX® of women with osteoporosis.
    Baji P; Gulácsi L; Horváth C; Brodszky V; Rencz F; Péntek M
    Arch Osteoporos; 2017 Dec; 12(1):4. PubMed ID: 28004298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX.
    McCloskey EV; Johansson H; Oden A; Austin M; Siris E; Wang A; Lewiecki EM; Lorenc R; Libanati C; Kanis JA
    J Bone Miner Res; 2012 Jul; 27(7):1480-6. PubMed ID: 22431426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FRAX® probabilities and risk of major osteoporotic fracture in France.
    Couris CM; Chapurlat RD; Kanis JA; Johansson H; Burlet N; Delmas PD; Schott AM
    Osteoporos Int; 2012 Sep; 23(9):2321-7. PubMed ID: 22179418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High fracture probability with FRAX usually indicates densitometric osteoporosis: implications for clinical practice.
    Leslie WD; Majumdar SR; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA;
    Osteoporos Int; 2012 Jan; 23(1):391-7. PubMed ID: 21365460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fracture risk among treatment-naïve postmenopausal women with osteopenia in Greece: results from the "ACROSS" study.
    Anastasilakis AD; Makras P
    Arch Osteoporos; 2020 Oct; 15(1):163. PubMed ID: 33067646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis plan.
    Vandenput L; Johansson H; McCloskey EV; Liu E; Åkesson KE; Anderson FA; Azagra R; Bager CL; Beaudart C; Bischoff-Ferrari HA; Biver E; Bruyère O; Cauley JA; Center JR; Chapurlat R; Christiansen C; Cooper C; Crandall CJ; Cummings SR; da Silva JAP; Dawson-Hughes B; Diez-Perez A; Dufour AB; Eisman JA; Elders PJM; Ferrari S; Fujita Y; Fujiwara S; Glüer CC; Goldshtein I; Goltzman D; Gudnason V; Hall J; Hans D; Hoff M; Hollick RJ; Huisman M; Iki M; Ish-Shalom S; Jones G; Karlsson MK; Khosla S; Kiel DP; Koh WP; Koromani F; Kotowicz MA; Kröger H; Kwok T; Lamy O; Langhammer A; Larijani B; Lippuner K; Mellström D; Merlijn T; Nordström A; Nordström P; O'Neill TW; Obermayer-Pietsch B; Ohlsson C; Orwoll ES; Pasco JA; Rivadeneira F; Schei B; Schott AM; Shiroma EJ; Siggeirsdottir K; Simonsick EM; Sornay-Rendu E; Sund R; Swart KMA; Szulc P; Tamaki J; Torgerson DJ; van Schoor NM; van Staa TP; Vila J; Wareham NJ; Wright NC; Yoshimura N; Zillikens MC; Zwart M; Harvey NC; Lorentzon M; Leslie WD; Kanis JA
    Osteoporos Int; 2022 Oct; 33(10):2103-2136. PubMed ID: 35639106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of FRAX and the impact of self-reported falls among elderly in a general population: the HUNT study, Norway.
    Hoff M; Meyer HE; Skurtveit S; Langhammer A; Søgaard AJ; Syversen U; Dhainaut A; Skovlund E; Abrahamsen B; Schei B
    Osteoporos Int; 2017 Oct; 28(10):2935-2944. PubMed ID: 28668994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fracture probability assessed using FRAX
    Nakada T; Teranishi M; Ueda Y; Sone M
    Auris Nasus Larynx; 2018 Dec; 45(6):1173-1177. PubMed ID: 29784241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FRAX-based intervention and assessment thresholds for osteoporosis in Iran.
    Khashayar P; Keshtkar A; Ostovar A; Larijani B; Johansson H; Harvey NC; Lorentzon M; McCloskey E; Kanis JA
    Osteoporos Int; 2019 Nov; 30(11):2225-2230. PubMed ID: 31372709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations between periodontal disease, mandibular inferior cortex index and the osteoporotic fracture probability assessed by means of the fracture risk assessment body mass index tool.
    Kalinowski P; Różyło-Kalinowska I; Piskórz M; Bojakowska-Komsta U
    BMC Med Imaging; 2019 May; 19(1):41. PubMed ID: 31117973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Fracture Risk Assessment Tool (FRAX®): applications in clinical practice.
    Watts NB
    J Womens Health (Larchmt); 2011 Apr; 20(4):525-31. PubMed ID: 21438699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.